IGF Oncology, LLC
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome (NCT03175978) | IGF Oncology, LLC | 2018-02-21 |
Track IGF Oncology, LLC automatically
Every clearance here is in the API, with alerts when new ones post.